Fortress Biotech to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Sep 05, 2017 12:01 pm UTC| Business
NEW YORK, Sept. 05, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...
Biotricity FDA Submission Update
Sep 05, 2017 12:01 pm UTC| Business
REDWOOD CITY, Calif., Sept. 05, 2017 -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, is...
Sep 05, 2017 12:01 pm UTC| Business
BASKING RIDGE, N.J., Sept. 05, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and...
Select Sands Receives Offer to Purchase Its Ownership Position in Comstock Metals
Sep 05, 2017 12:01 pm UTC| Business
VANCOUVER, British Columbia, Sept. 05, 2017 -- Select Sands Corp. (“Select Sands” or the “Company”) (TSX-V:SNS) (OTC:SLSDF) announces that it has received an offer from SJ Strategic Investments, LLC, Gracetree...
Bio-Path Holdings to Present at the Rodman & Renshaw Annual Healthcare Conference
Sep 05, 2017 12:01 pm UTC| Business
HOUSTON, Sept. 05, 2017 -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic...
Editas Medicine to Participate in Morgan Stanley 15th Annual Global Healthcare Conference
Sep 05, 2017 12:01 pm UTC| Business
CAMBRIDGE, Mass., Sept. 05, 2017 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in a fireside chat at the Morgan Stanley 15th Annual Global...
Alder BioPharmaceuticals® to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
Sep 05, 2017 12:01 pm UTC| Business
BOTHELL, Wash., Sept. 05, 2017 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics today announced that it will webcast its...